Johansson, Björn
Daniel, Ana C. S.
Herbers, Claudia
Gerl, Matthias
Kretz, Florian T. A. http://orcid.org/0000-0002-8771-2187
Funding for this research was provided by:
Carl Zeiss Meditec AG
Article History
Received: 6 January 2020
Accepted: 1 June 2020
First Online: 11 June 2020
Ethics approval and consent to participate
: This study was approved by the following Ethical Committees: Medical Association Westfalen-Lippe and Westphalian Wilhelms University, Münster, Germany; Linköpings University, Linköping, Sweden; Bavarian State Medical Association, München, Germany. Written informed consent was obtained from all participants before inclusion. The study was performed in accordance with the tenets of the Declaration of Helsinki.
: Not applicable.
: Dr. med. Florian Kretz (FEBO) is a consultant for Carl Zeiss Meditec, Oculentis, Mynosis, Rayner, Biotech, Glaukos LensAR and Teleon Surgical. His research is partially financed by Carl Zeiss Meditec, PhysIOL, Santen, AVS, Oculentis, Acufocus, Hoya, Johnson & Johnson, iSTAR Medical, Mynosis, Biotech, Infinite Vision and Glaukos. He receives travel reimbursement and honoraria from Carl Zeiss Meditec, PhysIOL, Santen, AVS, Oculentis, Acufocus, Hoya, Nidek, Mynosis, Biotech, Infinite Vision and Glaukos. VSY, MST and LensAR. MD PhD Björn Johansson (FEBO) is a consultant for Alcon, Bausch & Lomb, Carl Zeiss Meditec, Johnson & Johnson and Théa Laboratoires. The other authors have no competing interests to declare.